Figure 1.
Graphic representation of conditioning regimen.
Table 1.
The characteristics of 17 patients treated with haploidentical HSCT.
Figure 2.
The Kaplan-Meier curve for the cumulative incidences of grade III–IV acute GVHD (A) and chronic GVHD (B).
Table 2.
Graft, acute GVHD, chronic GVHD, infection of virus and causes of death after haploidentical HSCT.
Figure 3.
Cumulative survival rate (Kaplan-Meier).